Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 10.70
+0.04 (0.38%)
Aug 27, 2026, 9:17 AM CET
Vicore Pharma Holding AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 428.59 | 578.15 | 1,156 | 333.62 | 256.8 | 294.2 |
Short-Term Investments | 477.05 | 588.59 | - | 149.15 | 4.94 | 77.28 |
Cash & Short-Term Investments | 905.64 | 1,167 | 1,156 | 482.77 | 261.74 | 371.48 |
Cash Growth | -3.35% | 0.93% | 139.45% | 84.44% | -29.54% | 16.55% |
Other Receivables | 7.45 | 16.24 | 19.76 | 3.13 | 2.18 | 1.42 |
Receivables | 7.45 | 16.24 | 19.76 | 3.13 | 2.18 | 1.42 |
Prepaid Expenses | 13.01 | 33.94 | 19.82 | 9.7 | 5.87 | 5.03 |
Total Current Assets | 926.1 | 1,217 | 1,196 | 495.6 | 269.79 | 377.93 |
Property, Plant & Equipment | - | - | - | 0.03 | 0.12 | 0.4 |
Long-Term Investments | - | - | - | - | - | 5.41 |
Other Intangible Assets | - | - | - | 2.22 | 68.1 | 67.43 |
Other Long-Term Assets | 3.77 | 1.71 | - | - | - | - |
Total Assets | 929.87 | 1,219 | 1,196 | 497.84 | 338.01 | 451.17 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 20.01 | 39.47 | 29.97 | 17.92 | 23.5 | 23.98 |
Accrued Expenses | 49.46 | 65.8 | 15.75 | 14.65 | 18.22 | 40.14 |
Current Portion of Leases | - | - | - | - | 0.07 | - |
Current Income Taxes Payable | - | 0.06 | 1.93 | 1.13 | 0.76 | 0.34 |
Other Current Liabilities | 3.57 | 13.1 | 18.04 | 7.27 | 3.88 | 1.26 |
Total Current Liabilities | 73.04 | 118.43 | 65.69 | 40.96 | 46.42 | 65.72 |
Long-Term Leases | - | - | - | - | - | 0.32 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.59 | 0.91 | 1.21 |
Other Long-Term Liabilities | 3.2 | 4.74 | 0.56 | 0.9 | 1.6 | 0.6 |
Total Liabilities | 76.25 | 123.18 | 66.25 | 42.45 | 48.92 | 67.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 140.76 | 140.76 | 117.29 | 55.86 | 40.92 | 35.88 |
Additional Paid-In Capital | - | 2,876 | 2,454 | 1,674 | 1,211 | 1,022 |
Retained Earnings | - | -1,921 | -1,442 | -1,274 | -962.65 | -674.23 |
Comprehensive Income & Other | 712.86 | - | - | - | - | - |
Shareholders' Equity | 853.63 | 1,095 | 1,129 | 455.39 | 289.08 | 383.32 |
Total Liabilities & Equity | 929.87 | 1,219 | 1,196 | 497.84 | 338.01 | 451.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | - | 0.07 | 0.32 |
Net Cash (Debt) | 905.64 | 1,167 | 1,156 | 482.77 | 261.68 | 371.16 |
Net Cash Growth | -3.35% | 0.93% | 139.45% | 84.49% | -29.50% | 16.50% |
Net Cash Per Share | 3.44 | 4.86 | 8.45 | 5.00 | 3.62 | 5.33 |
Filing Date Shares Outstanding | 281.53 | 281.53 | 234.58 | 111.72 | 81.85 | 71.76 |
Total Common Shares Outstanding | 281.53 | 281.53 | 234.58 | 111.72 | 81.85 | 71.76 |
Working Capital | 853.06 | 1,098 | 1,130 | 454.64 | 223.37 | 312.21 |
Book Value Per Share | 3.03 | 3.89 | 4.81 | 4.08 | 3.53 | 5.34 |
Tangible Book Value | 853.63 | 1,095 | 1,129 | 453.17 | 220.98 | 315.89 |
Tangible Book Value Per Share | 3.03 | 3.89 | 4.81 | 4.06 | 2.70 | 4.40 |
Machinery | - | - | - | 0.15 | 0.15 | 0.15 |